SG
Sambasivarao Gaddipati
About Sambasivarao Gaddipati
Data last updated:
Sambasivarao Gaddipati is a Director at Vyas Cancer Research Private Limited (since 2015) and Director at Eliczen Lifesciences Private Limited (since 2016). The companies operate in Healthcare. The largest current company by reported revenue is Vyas Cancer Research Private Limited at ₹92.4 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Oct 2015 | 2015 | ₹92.4 Lakh (FY 2022) | Active | |
| Director | 11 Aug 2016 | 2016 | Active |
Board colleagues of Sambasivarao Gaddipati
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hima Bindu Gaddipati | 07288404 | Vyas Cancer Research Private Limited , Eliczen Lifesciences Private Limited | Managing Director |
| Mandar Vivekanand Kulkarni | 08349630 | Vyas Cancer Research Private Limited , Eliczen Lifesciences Private Limited | Director |
| Rani Rai | Vyas Cancer Research Private Limited | Company Secretary | |
| Pallavi Purushottam Joshi | 08865872 | Eliczen Lifesciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sambasivarao Gaddipati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sambasivarao Gaddipati
Sambasivarao Gaddipati currently holds 2 directorships: Vyas Cancer Research Private Limited (Director, since 07 Oct 2015, revenue ₹92.4 Lakh (FY 2022)); Eliczen Lifesciences Private Limited (Director, since 11 Aug 2016).
Sambasivarao Gaddipati was first appointed on 07 Oct 2015 as Director at Vyas Cancer Research Private Limited. The most recent appointment on record is 11 Aug 2016 at Eliczen Lifesciences Private Limited.
The current boards of Sambasivarao Gaddipati's companies include Hima Bindu Gaddipati (Vyas Cancer Research Private Limited), Mandar Vivekanand Kulkarni (Vyas Cancer Research Private Limited), Rani Rai (Vyas Cancer Research Private Limited), Pallavi Purushottam Joshi (Eliczen Lifesciences Private Limited).